Dr. Yin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
Boston, MA 02114Phone+1 617-523-7900
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 2015 - 2017
Detroit Medical Center/Wayne State UniversityResidency, Ophthalmology, 2012 - 2015- Detroit Medical Center/Wayne State University (Sinai-Grace)Internship, Transitional Year, 2011 - 2012
Wayne State UniversityPh.D., Vision science, 2008
Capital University of Medical SciencesClass of 2003
Certifications & Licensure
MA State Medical License 2015 - 2025
MI State Medical License 2011 - 2015- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 35 citationsRegulatory T Cells in Angiogenesis.Zala Lužnik, Sonia Anchouche, Reza Dana, Jia Yin
Journal of Immunology. 2020-11-15 - 14 citationsEfficacy of cyanoacrylate tissue adhesive in the management of corneal thinning and perforation due to microbial keratitis.Rohan Bir Singh, shuyan zhu, Ann Yung, Thomas H. Dohlman, Reza Dana
The Ocular Surface. 2020-08-19 - 39 citationsOutcomes of Cyanoacrylate Tissue Adhesive Application in Corneal Thinning and Perforation.Jia Yin, Rohan Bir Singh, Rani Al Karmi, Ann Yung, Man Yu
Cornea. 2019-06-01
Journal Articles
- Association of Α-melanocyte–Stimulating Hormone with Corneal Endothelial Cell Survival During Oxidative Stress and Inflammation-Induced Cell Loss in Donor TissueUla V Jurkunas, Jia Yin, Reza Dana, JAMA Ophthalmology
Press Mentions
Your Red, Itchy Eyes Might Be from a Condition Called Pinguecula — Here's How to TellFebruary 5th, 2021- Dana-Farber Collaborates with Mass. Eye and Ear to Rebuild Damaged Corneas Using Patients’ Own Stem Cells for First Time in United StatesSeptember 1st, 2020
- Cell Therapy That Repairs Cornea Damage with Patient’s Own Stem Cells Achieves Positive Phase I Trial ResultsAugust 19th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
